Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2015

01-06-2015 | Research Article

Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China

Authors: Jun Liu, Zhongliang Zhou, Shimin Yang, Bianling Feng, Jun Zhao, Hua Liu, Haiyan Huang, Yu Fang

Published in: International Journal of Clinical Pharmacy | Issue 3/2015

Login to get access

Abstract

Background Hospital pharmacists can make a considerable contribution to the spontaneous reporting system of adverse drug reactions. The factors that influence adverse drug reaction reporting among hospital pharmacists remain largely unknown in China. Objective This study aims to identify factors that affect hospital pharmacist-led adverse drug reaction reporting in Xi’an, and to obtain suggestions from pharmacists about how to improve the current adverse drug reaction reporting system. Setting Hospital settings throughout Xi’an, a region of Western China. Method A matched case–control study was conducted on a population of 2,814 hospital pharmacists in Xi’an during 2011. Cases included all pharmacists who had reported at least one adverse drug reaction between 2008 and 2010 and agreed to participate in the study (186/204; 91.2 %); controls (n = 372) were pharmacists who had not reported any adverse drug reaction during the same period. A self-administered questionnaire was distributed to the participants. Logistic regression was performed to evaluate the association between indicator variables and the outcome of having reported at least one adverse drug reaction. Main outcome measure Pharmacists’ knowledge, attitude and practice towards adverse drug reaction reporting and factors affecting reporting. Results Higher professional title (adjusted OR 1.44; 95 % CI 1.07–1.94; p = 0.018), having received training about adverse drug reaction reporting (1.64; 1.04–2.57; p = 0.032), better knowledge about reporting (1.53; 1.12–2.08; p = 0.007), “lack of access to adverse drug reaction reporting form” (0.29; 0.12–0.72; p = 0.008) was independently associated with adverse drug reaction reporting. Clinical pharmacists were more likely to report an adverse drug reaction than dispensary pharmacists (1/adjusted OR 5.26; p < 0.001), pharmacy administrators (5.00; p = 0.003), and other technicians (5.56; p = 0.001). Conclusions Higher professional title, having received training, mastering knowledge about reporting, and being a clinical pharmacist were positive predictors of pharmacist-led adverse drug reaction reporting. Lack of access to reporting forms was a negative predictor. Continuous training and establishing incentive mechanisms are needed to promote adverse drug reaction reporting among hospital pharmacists.
Literature
1.
go back to reference Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200–5.CrossRefPubMed Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200–5.CrossRefPubMed
2.
go back to reference Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. JAMA. 1997;277(4):301–6.CrossRefPubMed Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. JAMA. 1997;277(4):301–6.CrossRefPubMed
3.
go back to reference Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329(7456):15–9.CrossRefPubMedCentralPubMed Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329(7456):15–9.CrossRefPubMedCentralPubMed
4.
go back to reference Wise L, Parkinson J, Raine J, Breckenridge A. New approaches to drug safety: a pharmacovigilance tool kit. Nat Rev Drug Discov. 2009;8(10):779–82.PubMed Wise L, Parkinson J, Raine J, Breckenridge A. New approaches to drug safety: a pharmacovigilance tool kit. Nat Rev Drug Discov. 2009;8(10):779–82.PubMed
5.
go back to reference Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ, Green M, Andrews LG, et al. Physician reporting of adverse drug reactions. JAMA. 1990;263(13):1785–8.CrossRefPubMed Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ, Green M, Andrews LG, et al. Physician reporting of adverse drug reactions. JAMA. 1990;263(13):1785–8.CrossRefPubMed
6.
go back to reference Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–96.CrossRefPubMed Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–96.CrossRefPubMed
8.
go back to reference Du W, Guo JJ, Jing Y, Li X, Kelton CM. Drug safety surveillance in China and other countries: a review and comparison. Value Health. 2008;11(Suppl 1):S130–6.CrossRefPubMed Du W, Guo JJ, Jing Y, Li X, Kelton CM. Drug safety surveillance in China and other countries: a review and comparison. Value Health. 2008;11(Suppl 1):S130–6.CrossRefPubMed
10.
go back to reference Ekman E, Bäckström M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol. 2009;65(1):43–6.CrossRefPubMed Ekman E, Bäckström M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol. 2009;65(1):43–6.CrossRefPubMed
11.
go back to reference Aagaard L, Stenver D, Hansen E. Structures and processes in spontaneous ADR reporting systems: a comparative study of Australia and Denmark. Pharm World Sci. 2008;30(5):563–70.CrossRefPubMed Aagaard L, Stenver D, Hansen E. Structures and processes in spontaneous ADR reporting systems: a comparative study of Australia and Denmark. Pharm World Sci. 2008;30(5):563–70.CrossRefPubMed
12.
go back to reference Van Grootheest AC, van Puijenbroek EP, de Jong-van den Berg LT. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(3):205–10.CrossRefPubMed Van Grootheest AC, van Puijenbroek EP, de Jong-van den Berg LT. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(3):205–10.CrossRefPubMed
13.
go back to reference Ahmad SR, Freiman JP, Graham DJ, Nelson RC. Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA. Pharmacoepidemiol Drug Saf. 1996;5(1):1–7.CrossRefPubMed Ahmad SR, Freiman JP, Graham DJ, Nelson RC. Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA. Pharmacoepidemiol Drug Saf. 1996;5(1):1–7.CrossRefPubMed
14.
go back to reference Lee A, Bateman DN, Edwards C, Smith JM, Rawlins MD. Reporting of adverse drug reactions by hospital pharmacists: pilot scheme. BMJ. 1997;315(7107):519.CrossRefPubMedCentralPubMed Lee A, Bateman DN, Edwards C, Smith JM, Rawlins MD. Reporting of adverse drug reactions by hospital pharmacists: pilot scheme. BMJ. 1997;315(7107):519.CrossRefPubMedCentralPubMed
15.
go back to reference Wang HC, Chen LY, Lau AH. Pharmacy practice and education in the People’s Republic of China. Ann Pharmacother. 1993;27(10):1278–82.PubMed Wang HC, Chen LY, Lau AH. Pharmacy practice and education in the People’s Republic of China. Ann Pharmacother. 1993;27(10):1278–82.PubMed
18.
go back to reference Van Grootheest K, Olsson S, Couper M, de Jong-van den Berg LT. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13(7):457–64.CrossRefPubMed Van Grootheest K, Olsson S, Couper M, de Jong-van den Berg LT. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13(7):457–64.CrossRefPubMed
19.
go back to reference Belton KJ, The EPRG. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J of Clin Pharmacol. 1997;52(6):423–7.CrossRef Belton KJ, The EPRG. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J of Clin Pharmacol. 1997;52(6):423–7.CrossRef
20.
go back to reference Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623–7.CrossRefPubMedCentralPubMed Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623–7.CrossRefPubMedCentralPubMed
21.
go back to reference Qing L, Sumin Z, Huating C, Shiping F, Xin Y, Dong L, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J. 2004;117(6):856–61. Qing L, Sumin Z, Huating C, Shiping F, Xin Y, Dong L, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J. 2004;117(6):856–61.
22.
go back to reference Figueiras A, Tato F, Fontaiñas J, Gestal-Otero JJ. Influence of physicians’ attitudes on reporting adverse drug events: a case–control study. Med Care. 1999;37(8):809–14.CrossRefPubMed Figueiras A, Tato F, Fontaiñas J, Gestal-Otero JJ. Influence of physicians’ attitudes on reporting adverse drug events: a case–control study. Med Care. 1999;37(8):809–14.CrossRefPubMed
23.
go back to reference Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, et al. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med. 1988;148(7):1596–600.CrossRefPubMed Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, et al. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med. 1988;148(7):1596–600.CrossRefPubMed
24.
go back to reference Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians’ attitudes and adverse drug reaction reporting: a case–control study in Portugal. Drug Saf. 2005;28(9):825–33.CrossRefPubMed Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians’ attitudes and adverse drug reaction reporting: a case–control study in Portugal. Drug Saf. 2005;28(9):825–33.CrossRefPubMed
25.
go back to reference Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B. Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55(9):945–50.CrossRefPubMed Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B. Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55(9):945–50.CrossRefPubMed
26.
go back to reference Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2007;16(2):223–8.CrossRefPubMed Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2007;16(2):223–8.CrossRefPubMed
27.
go back to reference Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci. 1999;168(4):257–61.CrossRefPubMed Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci. 1999;168(4):257–61.CrossRefPubMed
28.
go back to reference Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23(2):165–72.CrossRefPubMed Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23(2):165–72.CrossRefPubMed
29.
go back to reference Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81–6.CrossRefPubMedCentralPubMed Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81–6.CrossRefPubMedCentralPubMed
30.
go back to reference Green CF, Mottram DR, Raval D, Proudlove C, Randall C. Community pharmacists’ attitudes to adverse drug reaction reporting. Int J Pharm Pract. 1999;7:92–9.CrossRef Green CF, Mottram DR, Raval D, Proudlove C, Randall C. Community pharmacists’ attitudes to adverse drug reaction reporting. Int J Pharm Pract. 1999;7:92–9.CrossRef
31.
go back to reference Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández-Díaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073–82.CrossRefPubMed Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández-Díaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073–82.CrossRefPubMed
32.
go back to reference Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case–control study in Portugal. Drug Saf. 2006;29(4):331–40.CrossRefPubMed Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case–control study in Portugal. Drug Saf. 2006;29(4):331–40.CrossRefPubMed
33.
go back to reference Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217–22.CrossRefPubMed Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217–22.CrossRefPubMed
34.
go back to reference Herdeiro MT, Polonia J, Gestal-Otero JJ, Figueiras A. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract. 2004;10(4):483–9.CrossRefPubMed Herdeiro MT, Polonia J, Gestal-Otero JJ, Figueiras A. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract. 2004;10(4):483–9.CrossRefPubMed
37.
go back to reference Schlienger RG, Lüscher TF, Haefeli WE, Schoenenberger RA. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21(3):110–5.CrossRefPubMed Schlienger RG, Lüscher TF, Haefeli WE, Schoenenberger RA. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21(3):110–5.CrossRefPubMed
38.
go back to reference Figueiras A, Tato F, Fontaiñas J, Takkouche B, Jesus Gestal-Otero J. Physicians’ attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract. 2001;7(4):347–54.CrossRefPubMed Figueiras A, Tato F, Fontaiñas J, Takkouche B, Jesus Gestal-Otero J. Physicians’ attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract. 2001;7(4):347–54.CrossRefPubMed
39.
go back to reference Van Grootheest AC, Mes K, de Jong-van den Berg Berg LT. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract. 2002;10:267–72.CrossRef Van Grootheest AC, Mes K, de Jong-van den Berg Berg LT. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract. 2002;10:267–72.CrossRef
40.
go back to reference Toklu H, Uysal M. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62.CrossRefPubMed Toklu H, Uysal M. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62.CrossRefPubMed
41.
go back to reference Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.CrossRefPubMedCentralPubMed Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.CrossRefPubMedCentralPubMed
42.
go back to reference Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: implications for pharmacists. Ther Clin Risk Manag. 2005;1(3):181–8.PubMedCentralPubMed Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: implications for pharmacists. Ther Clin Risk Manag. 2005;1(3):181–8.PubMedCentralPubMed
43.
go back to reference Green CF, Mottram DR, Rowe P, Brown AM. An investigation into adverse drug reaction monitoring by United Kingdom hospital pharmacy departments. Int J Pharm Pract. 1997;5:202–8.CrossRef Green CF, Mottram DR, Rowe P, Brown AM. An investigation into adverse drug reaction monitoring by United Kingdom hospital pharmacy departments. Int J Pharm Pract. 1997;5:202–8.CrossRef
Metadata
Title
Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China
Authors
Jun Liu
Zhongliang Zhou
Shimin Yang
Bianling Feng
Jun Zhao
Hua Liu
Haiyan Huang
Yu Fang
Publication date
01-06-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0065-8

Other articles of this Issue 3/2015

International Journal of Clinical Pharmacy 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.